ATE182216T1 - Verfahren zur quantifizierung von lbp in körperflüssigkeiten - Google Patents

Verfahren zur quantifizierung von lbp in körperflüssigkeiten

Info

Publication number
ATE182216T1
ATE182216T1 AT95909325T AT95909325T ATE182216T1 AT E182216 T1 ATE182216 T1 AT E182216T1 AT 95909325 T AT95909325 T AT 95909325T AT 95909325 T AT95909325 T AT 95909325T AT E182216 T1 ATE182216 T1 AT E182216T1
Authority
AT
Austria
Prior art keywords
lbp
body fluid
quantifying
quantifying lbp
subject
Prior art date
Application number
AT95909325T
Other languages
English (en)
Inventor
Mark Leslie White
Stephen Fitzhugh Carroll
Jeremy Kam-Kuen Ma
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Application granted granted Critical
Publication of ATE182216T1 publication Critical patent/ATE182216T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
AT95909325T 1994-01-24 1995-01-24 Verfahren zur quantifizierung von lbp in körperflüssigkeiten ATE182216T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/186,811 US5484705A (en) 1994-01-24 1994-01-24 Method for quantifying lipopolysaccharide binding protein

Publications (1)

Publication Number Publication Date
ATE182216T1 true ATE182216T1 (de) 1999-07-15

Family

ID=22686373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95909325T ATE182216T1 (de) 1994-01-24 1995-01-24 Verfahren zur quantifizierung von lbp in körperflüssigkeiten

Country Status (12)

Country Link
US (3) US5484705A (de)
EP (1) EP0741870B1 (de)
JP (1) JP3554331B2 (de)
CN (1) CN1132013C (de)
AT (1) ATE182216T1 (de)
AU (1) AU701710B2 (de)
DE (1) DE69510772T2 (de)
DK (1) DK0741870T3 (de)
ES (1) ES2133738T3 (de)
GR (1) GR3031303T3 (de)
MX (1) MX9602688A (de)
WO (1) WO1995020163A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5891618A (en) * 1994-01-24 1999-04-06 Xoma Corporation Method for quantifying LBP in body fluids
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
WO1997004008A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
PT914144E (pt) * 1996-05-10 2001-05-31 Univ Texas Utilizacoes terapeuticas de produtos de proteinas bip contra a meningococcemia humana
CA2255539C (en) * 1996-05-23 2005-09-27 Xoma Corporation Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
US5888973A (en) 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) * 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US5990082A (en) * 1997-10-22 1999-11-23 Xoma Corporation Uses of lipopolysaccharide binding protein
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
US7465555B2 (en) * 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis
EP1573054A4 (de) * 2002-11-12 2005-12-28 Becton Dickinson Co Sepsis- oder sirs-diagnose mittels biomarkerprofilen
MXPA05005071A (es) * 2002-11-12 2005-07-22 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
BR0316232A (pt) * 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US20060157647A1 (en) * 2005-01-18 2006-07-20 Becton, Dickinson And Company Multidimensional liquid chromatography/spectrometry
KR20080006617A (ko) 2005-04-15 2008-01-16 백톤 디킨슨 앤드 컴퍼니 패혈증의 진단
JP5537416B2 (ja) * 2007-04-26 2014-07-02 アデプト テクノロジー， インコーポレイテッド 真空把持装置
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
US7846678B2 (en) * 2008-08-18 2010-12-07 BioDtech, Inc. Enhancing endotoxin detection
JP5674664B2 (ja) * 2008-09-04 2015-02-25 ベックマン コールター， インコーポレイテッド パンキナーゼ活性化およびシグナリング経路の評価
CN104407156B (zh) * 2014-12-05 2016-03-16 重庆中元生物技术有限公司 检测多糖结合蛋白(lbp)的胶乳增强免疫比浊试剂盒及其制备方法
CN109507127A (zh) * 2018-12-07 2019-03-22 上海浩港生物技术有限公司 一种用于检测人类血液中lbp含量的试剂盒
CN109507323A (zh) * 2018-12-07 2019-03-22 上海浩港生物技术有限公司 一种用质谱仪检测人类血液中lbp含量的试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310879A (en) * 1985-04-30 1994-05-10 The Scripps Research Institute Antibodies which immunoreact with lapine lipopolysaccharide binding protein (LBP)
US5245013A (en) * 1985-04-30 1993-09-14 Richard Ulevitch Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides
EP0220308A1 (de) * 1985-04-30 1987-05-06 Scripps Clinic And Research Foundation Die endotoxische aktivität von lipopolysacchariden modulierendes akutphasenprotein, zusammensetzungen und verfahren
JP2744130B2 (ja) * 1989-08-01 1998-04-28 スクリップス クリニック アンド リサーチ ファウンデーション 敗血症治療用組成物
AU2872792A (en) * 1991-09-26 1993-04-27 Incyte Pharmaceuticals, Inc. A new form of liposaccharide binding protein (lbp)
AU6522794A (en) * 1993-03-22 1994-10-11 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein and lipopolysaccharide binding protein levels and ratios thereof in diagnosis
AU6942994A (en) * 1993-04-30 1994-11-21 Incyte Pharmaceuticals, Inc. Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
US5731415A (en) * 1993-06-17 1998-03-24 Xoma Corporation Lipopolysaccharide binding protein derivatives
WO1995002414A1 (en) * 1993-07-14 1995-01-26 Xoma Corporation Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein

Also Published As

Publication number Publication date
EP0741870B1 (de) 1999-07-14
DE69510772D1 (de) 1999-08-19
US6274328B1 (en) 2001-08-14
WO1995020163A1 (en) 1995-07-27
DK0741870T3 (da) 1999-12-13
MX9602688A (es) 1997-05-31
DE69510772T2 (de) 1999-11-11
EP0741870A1 (de) 1996-11-13
CN1139485A (zh) 1997-01-01
AU701710B2 (en) 1999-02-04
HK1015174A1 (en) 1999-10-08
JP3554331B2 (ja) 2004-08-18
JPH09508465A (ja) 1997-08-26
US5484705A (en) 1996-01-16
AU1732195A (en) 1995-08-08
ES2133738T3 (es) 1999-09-16
US5804367A (en) 1998-09-08
CN1132013C (zh) 2003-12-24
GR3031303T3 (en) 1999-12-31

Similar Documents

Publication Publication Date Title
DE69510772D1 (de) Verfahren zur quantifizierung von lbp in körperflüssigkeiten
EP0987550A3 (de) Analytische Testvorrichtung und Verfahren zu ihrer Verwendung
ATE394658T1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE69932191D1 (de) Vorrichtung zur Untersuchung von Körperflüssigkeit
NO973444D0 (no) Fremgangsmåter og forbindelser for magnetrelaksometrisk påvisning av analytter, samt anvendelse av slike
DE69626683D1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
DE69109236D1 (de) Verfahren und Systeme zur Identifizierung von Flüssigkeiten und Bestimmung der Strömung.
EP1710253A3 (de) Tumormarker
DE59204440D1 (de) Verfahren zur Erkennung von Verbrennungsaussetzern.
EP0645630A3 (de) Verfahren zur Bestimmung der Anwesenheit eines Pivkas und Reagens dazu.
DE69105978D1 (de) Verfahren zur verminderung von störungen in einer fluoreszenzbestimmung.
DK0720745T3 (da) Fremgangsmåde til kvantificering af ekstracellulært BPI i legemsvæsker
DE3888998D1 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten.
DE69319752D1 (de) Verfahren zur identifizierung von analyten
FI854627A7 (fi) Menetelmä ja reagenssi plasmassa, seerumissa tai kokoveressä olevan vapaan tyroksiinin kvantitatiiviseksi määrittämiseksi.
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ATE67044T1 (de) Verfahren und vorrichtung zum bestimmen von schwellenwerten bei der teilchenanalyse einer fluessigkeit.
DE3684510D1 (de) Verfahren zur trennung von antifaktor viii:c-antikoerpern, insbesondere verwendbar fuer die reinigung des blutplasmas eines typ-a-haemophilen.
CA2181815A1 (en) Method for quantifying lbp in body fluids
DE69615460D1 (de) Verfahren und Vorrichtung zur Zuteilung von Transaktionsidentifikatoren
ATE211825T1 (de) Verfahren zur feststellung einer allergie
WO2003001212A3 (en) A method for diagnosing a person having multiple sclerosis
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
DE69627352D1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci-vermittelter neuropsychiatrischer krankheiten
ATE307201T1 (de) Srcr domäne-enthaltendes protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification